Scientists around the world have been searching for better ways to treat Alzheimer’s disease, a condition that slowly destroys memory and thinking ability.
Millions of families are affected by the disease, and the number of cases is expected to rise as populations continue to age.
Alzheimer’s disease is often linked to abnormal protein buildup in the brain. One of the most well-known proteins is amyloid-beta, which forms sticky plaques between brain cells. These plaques are believed to interfere with normal brain communication and contribute to memory decline.
For many years, researchers mainly focused on directly removing these plaques or stopping them from forming. Some newer drugs have shown limited success, but many treatments have also caused side effects or failed to provide large improvements.
Now, researchers from Spain, China, and the United Kingdom have developed a completely different strategy that may change how scientists think about Alzheimer’s disease.
The study was led by experts from the Institute for Bioengineering of Catalonia and West China Hospital Sichuan University. Their research was published in Signal Transduction and Targeted Therapy.
Instead of mainly targeting the plaques themselves, the researchers focused on restoring the brain’s natural ability to clean away harmful waste.
The brain has its own waste disposal system, which works through a network of blood vessels and protective cells known as the blood-brain barrier. This barrier acts like a gatekeeper. It carefully controls which substances can enter the brain and which materials should leave.
When people are healthy, the blood-brain barrier helps remove toxic waste products before they can cause damage. But scientists have discovered that in Alzheimer’s disease, this system slowly weakens.
As the barrier becomes damaged, toxic proteins such as amyloid-beta start building up in the brain. Blood flow may also become less healthy, which can further damage brain cells.
In recent years, many experts have started viewing Alzheimer’s disease as not only a disease of brain cells, but also a disease involving blood vessels and circulation problems.
The new study explored whether repairing this cleaning system could help the brain heal itself.
To test the idea, the researchers created tiny engineered particles called supramolecular nanoparticles. These particles are extremely small, much smaller than human cells.
Unlike most nanoparticles used in medicine, these particles were not simply used to carry another drug. The particles themselves acted as the treatment.
The scientists tested the therapy in mice specially bred to develop Alzheimer’s-like disease. These animals slowly develop amyloid-beta buildup and memory problems similar to those seen in human patients.
The results were dramatic.
Only one hour after the mice received the nanoparticle injections, researchers observed a huge reduction in amyloid-beta levels inside the brain. The amount of toxic protein dropped by about half.
The researchers then followed the animals over a much longer period to see whether the benefits would last.
In one striking experiment, a mouse that was already older and showing Alzheimer’s-like disease was treated with the nanoparticles. Six months later, the animal still behaved similarly to a healthy mouse and showed far fewer signs of memory decline.
Scientists believe the treatment works by restoring healthier function to the blood-brain barrier.
A very important protein called LRP1 appears to play a major role. This protein normally helps move amyloid-beta out of the brain and into the bloodstream, where it can be removed by the body.
But in Alzheimer’s disease, this transport system stops working properly. Toxic proteins begin collecting faster than the brain can clear them away.
The nanoparticles were carefully designed to interact with the LRP1 system in a balanced way. Researchers believe this may help “restart” the brain’s natural cleaning process.
One reason the findings are attracting attention is because the treatment focuses on repairing brain function rather than simply attacking plaques directly.
The researchers also highlighted the importance of blood vessels in brain health. The brain uses enormous amounts of energy and depends on a rich network of tiny blood vessels for oxygen and nutrients.
Scientists estimate there are around one billion capillaries in the human brain. Nearly every neuron is closely connected to blood vessels. Damage to this network may therefore have major effects on memory and thinking.
The study adds to growing evidence that blood vessel damage may be deeply connected to dementia progression.
Another interesting part of the research is the advanced engineering used to create the nanoparticles. The scientists carefully controlled the particles’ size and surface structure so they could interact precisely with receptors in the blood-brain barrier.
This level of precision may help avoid some of the delivery problems seen with other Alzheimer’s treatments. One major challenge in brain medicine is that many drugs cannot easily cross the blood-brain barrier safely.
The researchers believe their nanoparticles could eventually work alongside other Alzheimer’s treatments, including anti-amyloid drugs already being developed.
Even though the findings are exciting, experts stress that the therapy has only been tested in animals so far. Many treatments that work well in mice do not always succeed in human studies.
Still, the research represents an important step forward because it explores a completely different way of treating Alzheimer’s disease. Instead of only trying to destroy plaques, scientists are attempting to restore the brain’s own natural balance and waste-removal systems.
If you care about Alzheimer’s disease, please read studies that bad lifestyle habits can cause Alzheimer’s disease, and strawberries can be good defence against Alzheimer’s.
For more information about brain health, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
Source: Institute for Bioengineering of Catalonia (IBEC).
